Author Correction: BRAF<sup>V600E</sup>-mutant metastatic NSCLC: disease overview and treatment landscape.

导出 LinkOut

翻译打印收藏纠错

第一作者： David,Planchard

第一单位： Thoracic Cancer Group, Department of Medical Oncology, Gustave Roussy, Villejuif, France. david.planchard@gustaveroussy.fr.

作者： David,Planchard ^[1] ; Rachel E,Sanborn ^[2] ; Marcelo V,Negrao ^[3] ; Aria,Vaishnavi ^[4] ; Egbert F,Smit ^[5]

作者单位： Thoracic Cancer Group, Department of Medical Oncology, Gustave Roussy, Villejuif, France. david.planchard@gustaveroussy.fr. ^[1] Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA. ^[2] Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[3] Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[4] Department of Pulmonary Disease, Leiden University Medical Centre, Leiden, Netherlands. ^[5]

DOI 10.1038/s41698-024-00633-7

PMID 39009670

发布时间 2024-07-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

NPJ precision oncology

2024年8卷1期

142页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Author Correction: BRAF<sup>V600E</sup>-mutant metastatic NSCLC: disease overview and treatment landscape.

NPJ precision oncology

相似文献

NPJ precision oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Author Correction: BRAF<sup>V600E</sup>-mutant metastatic NSCLC: disease overview and treatment landscape.

NPJ precision oncology

相似文献

NPJ precision oncology

相关期刊

检索历史清除